Keywords: Daiichi Sankyo, Plexxikon, Roche, PLX4032, Malignant melanoma

Daiichi Sankyo broadens cancer pipeline buying Plexxikon for $805 million

Article | 01 March 2011

Japanese drug major Daiichi Sankyo (TYO: 4568) says that it has concluded an agreement to acquire Plexxikon, a privately-held pharmaceutical company ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Plexxikon

Daiichi Sankyo

Roche

Go to company listing